August 21, 2019
Each year at IDWeek, the Society recognizes the exemplary and outstanding legacies left behind by those for whom the memorial lectureships are named. Please join us at IDWeek 2019, Oct. 2-6 in Washington, DC, to hear these outstanding lectures. Register now.
IDSA’s Core Antimicrobial Stewardship (AS) Curriculum is now available for purchase via IDSA Academy. It is designed to provide ID fellows with a foundation in antimicrobial stewardship, regardless of their ultimate career plans, as well as ensure that we are training future leaders in the field.Read More
There’s still time to complete the 2019 ID physician compensation survey if you haven’t already! Our goal is to learn more about ID physician compensation so we can better understand and report on trends in the profession, and in turn, serve you better by advocating for fair compensation.Read More
One year after the 10th Ebola outbreak in the Democratic Republic of the Congo was announced and subsequently declared a Public Health Emergency of International Concern, IDSA physician members who cared for patients on the ground in the 2014 West Africa Ebola outbreak provide updates and expert analysis on the ongoing crisis in the DRC in this podcast.Read More
In a joint statement, the leaders of IDSA, HIVMA, PIDS, SHEA and American Society of Tropical Medicine and Hygiene (ASTMH) spoke out against the recent decision by the U.S. Customs and Border Patrol to withhold vaccinations against seasonal influenza from migrants in border detention facilities.Read More
In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Recombinant Herpes Zoster Vaccine in Autologous Stem Cell Transplant Recipients, UTI Treatment in Men: Longer is Not Better, and Can the Government Improve Mortality in Sepsis?Read More
A new report by the Centers for Disease Control and Prevention on the use of antibiotics in health care settings across the United States in 2018 shows that progress has been made to promote the appropriate use of infection-fighting drugs, but that strengthened and continued efforts are still needed to prevent the accelerating development of antibiotic-resistant bacteria.Read More
A new collection of articles highlighting the science and complexity of inclusion, diversity, access, and equity is now available online, part of an ongoing commitment to drive improvements within the field of infectious diseases and the Infectious Diseases Society of America (IDSA).Read More
Medicare Administrative Contractors (MACs) First Coast and Novitas Solutions, whose combined jurisdictions cover 12 states, Puerto Rico, the U.S. Virgin Islands and the District of Columbia, have proposed identical payment policies for Gastrointestinal Pathogen Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (DL38229) that other MACs may soon adopt.Read More
In a comment letter to the World Health Organization on the draft global immunization strategy the WHO is developing for 2021 through 2030, IDSA urges the WHO to include specific and measurable, global-level immunization targets on MMR, DTaP and IPV, among others, in the strategy.Read More
The IDWeek Mentorship Program Committee is recruiting new volunteers. The IDWeek Mentorship Program was developed to provide a platform for more ID mentorship opportunities.Read More
Data from a randomized trial of four investigational Ebola treatments showed significantly improved survival rates for two of the drugs.Read More
Infectious Disease News spoke with IDSA spokesperson Trish Perl, MD, MSc, FIDSA to get her perspective on recent study findings published in Infection Control & Hospital Epidemiology revealing that carbapenem-resistant A. baumannii (CRAB) colonization can persist for months.Read More